Australia, Aug. 11 -- Therakos LLC, owns the trademark (2649646) for 'METAVIVO THERAPEUTICS' till March 17, 2036.
Status: protected:
Registered/protected
Classes: 5 [Pharmaceutical preparations for the treatment of immune system related diseases and disorders, autoimmune diseases, cancer, inflammation and autoinflammation diseases by use in extracorporeal photopheresis, extracorporeal photo immune therapy, extracorporeal photo chemotherapy and cellular therapies.], 10 [Medical device, namely, therapeutic medical device for extracting blood from the body, separating blood, treating it extra corporally, and returning it to the body, used for extra corporeal photopheresis, extra corporeal photo immune therapy, extra corporeal photo chemotherapy, and cellular therapies.], 42 [Pharmaceutical research services; pharmaceutical products development.] and 44 [Medical and pharmaceutical consultation; medical services relating to extra corporeal photopheresis, extra corporeal photo immune therapy, extra corporeal photo chemotherapy, and cellular therapies.]
Type of Mark: Word
Date of Acceptance: May 18
Registration Advertised: Aug. 10
For further details contact Adrienne Love Stearns Weaver Miller Weissler Alhadeff & Sitterso.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2649646.
Disclaimer: Curated by HT Syndication.
